Open Access · CC BY 4.0
Correction to “circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”
MedComm · 2026-04 · 7 (4)
DOI: 10.1002/mco2.70703 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 17.03.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”. MedComm, 7(4). https://doi.org/10.1002/mco2.70703
Vancouver
Correction to “circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”. MedComm. 2026;7(4). doi:10.1002/mco2.70703
BibTeX
@article{euvimed2026,
title = {Correction to “circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”},
journal = {MedComm},
year = {2026},
volume = {7},
number = {4},
doi = {10.1002/mco2.70703}
}
EUVIMED